- Investing Ideas
- Indian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Indian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
4
1 new
High return on equity, past performance and sound balance sheet.
4 companies
Procter & Gamble Health
Market Cap: ₹103.2b
Manufactures and markets pharmaceuticals and chemical products in India and internationally.
New
500126
₹6,220.00
7D
3.2%
1Y
7.2%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹371.8b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,194.55
7D
0.3%
1Y
-35.4%
Abbott India
Market Cap: ₹555.6b
Operates as a pharmaceutical company in India.
500488
₹26,145.70
7D
-0.6%
1Y
-17.4%
Acutaas Chemicals
Market Cap: ₹261.9b
Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
ACUTAAS
₹3,198.70
7D
5.3%
1Y
184.8%